Latest period
$69.86M
YoY change
-44.9%
5Y CAGR
-29.9%
Peak year (2020)
$475.53M
Latest annual
$80.41M
Stock-Based Compensation history chart for Teladoc Health (TDOC) from 2013 to 2025
Latest: $80.41M
Stock-Based Compensation growth chart for Teladoc Health (TDOC) from 2013 to 2025
Latest: -44.9%
Stock-Based Compensation history table for Teladoc Health (TDOC) from 2013 to 2025
| 2025 | $80.41M | -44.9% | −$65.54M | ||
| 2024 | $145.95M | -27.6% | −$55.60M | ||
| 2023 | $201.55M | — | +$201.55M | ||
| 2022 | $0.00 | — | $0.00 | ||
| 2021 | $0.00 | -100.0% | −$475.53M | ||
| 2020 | $475.53M | +612.9% | +$408.83M | ||
| 2019 | $66.70M | +52.4% | +$22.93M | ||
| 2018 | $43.77M | +43.0% | +$13.17M | ||
| 2017 | $30.60M | +296.2% | +$22.87M | ||
| 2016 | $7.72M | +151.2% | +$4.65M | ||
| 2015 | $3.08M | +476.9% | +$2.54M | ||
| 2014 | $533.00K | +78.9% | +$235.00K | ||
| 2013 | $298.00K | — | — |
- 2025$80.41M-44.9%
- 2024$145.95M-27.6%
- 2023$201.55M—
- 2022$0.00—
- 2021$0.00-100.0%
- 2020$475.53M+612.9%
- 2019$66.70M+52.4%
- 2018$43.77M+43.0%
- 2017$30.60M+296.2%
- 2016$7.72M+151.2%
- 2015$3.08M+476.9%
- 2014$533.00K+78.9%
- 2013$298.00K—
Stock-Based Compensation values are taken from Teladoc Health's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Teladoc Health (TDOC)
Stock-Based Compensation for Teladoc Health (TDOC): headline value $69.86M · YoY -44.9%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Teladoc Health (TDOC) stock-based compensation totalled $80.41M – plunged 44.9% year-over-year.
Teladoc Health stock-based compensation compound annual growth for the 2020–2025 (5 years) window is -29.9%, with a net decline across the window.
$475.53M stands as the all-time-high annual stock-based compensation, posted in 2020, against a low of $0.00 during 2021.
Teladoc Health Stock-Based Compensation by Year
Teladoc Health Stock-Based Compensation 2025: $80.41M
Teladoc Health posted stock-based compensation of $80.41M in 2025, plunged 44.9% below 2024.
Teladoc Health Stock-Based Compensation 2024: $145.95M
In 2024, Teladoc Health reported stock-based compensation of $145.95M, declined 27.6% below 2023.
Teladoc Health Stock-Based Compensation 2023: $201.55M
Teladoc Health stock-based compensation in 2023 was $201.55M.
Teladoc Health Stock-Based Compensation 2022: $0.00
Teladoc Health stock-based compensation in 2022 was $0.00.
Teladoc Health Stock-Based Compensation 2021: $0.00
Teladoc Health stock-based compensation in 2021 was $0.00.
See more financial history for Teladoc Health (TDOC).
Sector peers by Stock-Based Compensation
Healthcare peers of Teladoc Health (TDOC), ranked by their latest stock-based compensation
| $1.35B | |
| $971.00M | |
| $955.00M | |
| $626.00M | |
| $0.00 | |
| $0.00 | |
| $0.00 | |
| $0.00 |
- $1.35B
- $971.00M
- $955.00M
- $626.00M
- $0.00
- $0.00
- $0.00
- $0.00
Frequently asked questions
Teladoc Health (TDOC) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation